About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Breast Cancer Could be Treated With a Diabetes Drug

by Mohamed Fathima S on March 14, 2019 at 10:53 AM
Font : A-A+

Breast Cancer Could be Treated With a Diabetes Drug

Resistant breast cancers that currently have no targeted therapy can now be treated with a repurposed common diabetes drug and another drug used in the treatment of a group of inherited and acquired disorders reveals research.

The study, led by the University of Chicago, showed that the two existing drugs named metformin and haemin suppress tumor growth in mice, Xinhua reported.

Advertisement


"This is the first joint use of these two drugs. We think we have elucidated a new mechanism, something basic and fundamental, and found ways to use it," said Marsha Rosner, Professor at the varsity.

The researchers found that the primary anti-cancer target for haemin is a transcription factor known as BACH1 (BTB and CNC homology1). This protein is often highly expressed in triple negative breast cancers and is required for metastasis.
Advertisement

BACH1 targets mitochondrial metabolism and can suppress a key source of cellular energy. When BACH1 is high, this energy source is shut down, the report said.

However, when cancer cells were treated with haemin, BACH1 was reduced, causing BACH1-depleted cancer cells to change metabolic pathways. This caused cancers that are vulnerable to metformin to suppress mitochondrial respiration.

"We found that this novel combination, haemin plus metformin, can suppress tumor growth, and we validated this in mouse tumor models," explained Jiyoung Lee from the varsity.

The findings can extend beyond breast cancer. BACH1 expression is enriched not only in triple negative breast cancers, but is also seen in many other cancers including lung, kidney, uterus, prostate and acute myeloid leukemia, the researchers noted.

However, neither of the drugs were originally designed to treat cancer.

Metformin, discovered in 1922 and used clinically since 1957, was developed to treat Type-2 diabetes. It decreases glucose production by the liver and increases insulin sensitivity.

Haemin, marketed as panhematin, was first crystallized from blood in 1853. It is now used to treat defects of haemin synthesis. These defects can cause porphyrias, a group of inherited and acquired disorders.



Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Diabetic Retinopathy Drug Toxicity Breast Biopsy Diabetes Diabetic Diet Pagets disease of the breast Mastitis Diabetes - Essentials Cancer and Homeopathy 

Most Popular on Medindia

Selfie Addiction Calculator Loram (2 mg) (Lorazepam) Blood Donation - Recipients Accident and Trauma Care Blood - Sugar Chart Diaphragmatic Hernia Daily Calorie Requirements Sanatogen Post-Nasal Drip Find a Hospital
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Breast Cancer Could be Treated With a Diabetes Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests